StocksMedium•1 October 2026•
1 min read
Nexalin Technology Signs Exclusive South American Distribution and Manufacturing Deal
Key Facts
1Nexalin Technology signed a definitive exclusive distribution and local manufacturing agreement covering Brazil and six other South American countries.
2The agreement includes an initial commercialization program for 100 ANVISA-approved Nexalin Sync devices.
Nexalin Technology signed a definitive exclusive distribution and local manufacturing agreement covering Brazil and six other South American countries. GlobeNewswire reported that the deal includes an initial commercialization program for 100 ANVISA-approved Nexalin Sync devices, signaling a strategic transition toward revenue generation.
NXL closed at $4.28 on September 30, 2026, after reaching a session high of $4.5 and a low of $4.1. The company aims to leverage established distribution networks and local manufacturing to penetrate a market of over 300 million people across the South American region.